- Home
- SHFS vs INKT Comparison
SHFS vs INKT Comparison
Compare SHFS & INKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SHFS
- INKT
- Stock Information
- Founded
- SHFS 2015
- INKT 2017
- Country
- SHFS United States
- INKT United States
- Employees
- SHFS N/A
- INKT N/A
- Industry
- SHFS Finance: Consumer Services
- INKT Medicinal Chemicals and Botanical Products
- Sector
- SHFS Finance
- INKT Health Care
- Exchange
- SHFS Nasdaq
- INKT Nasdaq
- Market Cap
- SHFS 20.8M
- INKT 28.9M
- IPO Year
- SHFS N/A
- INKT 2021
- Fundamental
- Price
- SHFS $2.17
- INKT $7.04
- Analyst Decision
- SHFS
- INKT Strong Buy
- Analyst Count
- SHFS 0
- INKT 2
- Target Price
- SHFS N/A
- INKT $37.50
- AVG Volume (30 Days)
- SHFS 9.5K
- INKT 14.8K
- Earning Date
- SHFS 08-13-2025
- INKT 08-12-2025
- Dividend Yield
- SHFS N/A
- INKT N/A
- EPS Growth
- SHFS N/A
- INKT N/A
- EPS
- SHFS N/A
- INKT N/A
- Revenue
- SHFS $13,956,453.00
- INKT N/A
- Revenue This Year
- SHFS N/A
- INKT N/A
- Revenue Next Year
- SHFS N/A
- INKT N/A
- P/E Ratio
- SHFS N/A
- INKT N/A
- Revenue Growth
- SHFS N/A
- INKT N/A
- 52 Week Low
- SHFS $1.84
- INKT $4.56
- 52 Week High
- SHFS $14.86
- INKT $13.79
- Technical
- Relative Strength Index (RSI)
- SHFS 43.20
- INKT 40.47
- Support Level
- SHFS $2.03
- INKT $6.91
- Resistance Level
- SHFS $2.40
- INKT $7.51
- Average True Range (ATR)
- SHFS 0.14
- INKT 0.30
- MACD
- SHFS 0.01
- INKT -0.04
- Stochastic Oscillator
- SHFS 42.47
- INKT 0.00
About SHFS SHF Holdings Inc.
SHF Holdings Inc is a financial services provider to cannabis-related businesses. It offers reliable access to banking solutions for cannabis, hemp, CBD, and ancillary operators, making communities safer, driving growth in local economies, and fostering long-term partnerships. The group, through its financial institution clients, implements accountability, transparency, monitoring, reporting, and risk mitigation measures while meeting Bank Secrecy Act obligations in line with FinCEN guidance on cannabis-related businesses. Its services include Program Management Support, Customer Generation, Ongoing Program Auditing, and Compliance Monitoring among others.
About INKT MiNK Therapeutics Inc.
MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company pioneering the discovery, development, and commercialization of allogeneic invariant natural killer T (iNKT) cell therapies to treat cancer and other immune-mediated diseases. The company is advancing a pipeline of both native and next generation engineered iNKT programs, with a platform designed to facilitate scalable and reproducible manufacturing for off-the-shelf delivery.